#398 Bayer's Expert Mondays 2024 - How does Big Pharma Evaluate Partnering Offers? + Tips on Preparing Non-Conf. Pitch Decks
#399 Revolutionizing the production of novel diagnostics with cost-effective Roll-to-Roll imprinting
#400 AskBio Receives European Commission Orphan Drug Designation through its EU-Based subsidiary BrainVectis for AB-1003, a Novel Investigational AAV Gene Therapy for the Treatment of Limb-Girdle Muscular Dystrophy (LGMD)
#401 The fatal role of T cells in COVID-19
#402 Young adults at highest risk of weight gain
#403 1st Immunology & Inflammation (I & I) Conference
#404 Ludovic Vallier grows liver tissue from stem cells
#405 Cluster Advisory Board
#406 GeneQuine Biotherapeutics Secures More Than €9 Million in Series A Financing and Non-Dilutive Funding to Advance Gene Therapy Pipeline for Musculoskeletal Diseases
#407 Workshop on UX Design/ Usability
#408 Europe looks to cells for a healthier future
#409 Big step for the therapy of type 2 diabetes
#410 Layer-by-Layer nanoscale coatings, surface modification, micro encapsulation and bead based microsensors (pH, temperature, oxygen, chloride, bioanalysis) for co-development of innovative applications
#411 In Portrait | The Research Center "Der Simulierte Mensch” (The Simulated Human) (Si-M)
#412 EIT Health Summits
#413 Leveraging Powerful Instruments to boost Co-Innovation with Taiwan - Biomedical and IoT as Examples
#414 Million euro support for MyoPax
#415 More than the cheese of the future – Formo wants to create sustainability with biotech
#416 How the body switches out of “fight” mode - Study in Nature unlocks how cortisone inhibits inflammation
#417 ProBioGen announces that their proprietary vaccine production cell line AGE1.CR.pIX® has been successfully used to manufacture a viral vector product that has advanced into a randomized phase II clinical trial.
#418 Glycobiotechnology Summer School
#419 Crunchy, crispy and cult – Food analysis and nutrition trends: challenges for analysis and evaluation
#420 Interview with Björn von Siemens, Co-Founder of caresyntax
#421 JPT launches The Human Proteome Peptide Catalog
#422 Bayer’s darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free survival with a favorable safety profile compared to placebo plus ADT in non-metastatic castration-resistant prostate cancer
#423 International Biotechnology Innovation Days (IBID)
#424 Revolutionary milk analysis platform allows for multiplex analysis of 100 antibiotic residues and toxins in a single test
#425 BIO-EUROPE SPRING 2022
#426 Review: "The Product is the Process – Is it?" Manufacturing and Translation of ATMPs and Tissue- & Cell-based products
#427 KNAUER finalist at German renowned award for medium-sized businesses 2018
#428 C-VoUCHER 1st call for adopters
#429 Startup Academy: Founding a GmbH
#430 LEDGER: The Venture Builder for Human Centric Solutions
#431 Takeda – International Tradition in the Capital Region
#432 These commercialisation workshops provide an introduction to key concepts for early and mid-stage businesses
#433 Protecting your innovation – Workshop on intellectual property and regulatory exclusivity in biotech & pharma
#434 COVID-19: What is driving the escalating hyperinflammation
#435 Caresyntax Raises $100 Million to Make Surgery Smarter and Safer
#436 Chiba AI-IoT-Healthcare Invitation Program 2020 ～Meet the Kashiwanoha - a New Innovative Hub near Tokyo～
#437 Potsdam International Forum – Innovation Hubs for Regional Development: Experiences, Challenges, Solutions
#438 Scannexus and MRI.TOOLS announce collaboration
#439 Stray proteins cause genetic disorders
#440 Cambrium Secures €8 Million in Seed Funding to Commercialize New Class of Performance Molecules
#441 19th Annual Biotech in Europe Investor Forum
#442 A neuromuscular model for drug development
#443 Interview: Clemens Kaiser, Chief Executive Officer at Sanofi-Aventis Deutschland GmbH
#444 Bayer’s Expert Mondays - Elevate your healthcare innovation to the next level
#445 VC Investor Breakfast
#446 Bayer’s Expert Mondays - Elevate your healthcare innovation to the next level
#447 Bayer’s Expert Mondays - Elevate your healthcare innovation to the next level
#448 Bayer’s Expert Mondays - Elevate your healthcare innovation to the next level
#449 Bayer’s Expert Mondays - Elevate your healthcare innovation to the next level
#450 Bayer’s Expert Mondays - Elevate your healthcare innovation to the next level
#451 Bayer’s Expert Mondays - Elevate your healthcare innovation to the next level
#452 Bayer’s Expert Mondays - Elevate your healthcare innovation to the next level
#453 Bayer’s Expert Mondays - Elevate your healthcare innovation to the next level
#454 Bayer’s Expert Mondays - Elevate your healthcare innovation to the next level
#455 Transmission of measles virus: Interaction with two cell receptors is required
#456 Bayer’s Expert Mondays - Elevate your healthcare innovation to the next level
#457 NewSpaceVision Conference 2018
#458 Scientists of the DIfE have revealed expression patterns of key receptors in the mouse hypothalamus
#459 Bayer’s Expert Mondays - Elevate your healthcare innovation to the next level
#460 MedtecLIVE with T4M brings medical technology together
#461 Golden Ticket Competition
#462 “The Product is the Process – Is it?” Manufacturing and Translation of ATMP and Tissue-& Cell-based products
#463 Sensor solution for checking electrolyte balance
#464 Bayer’s Expert Mondays - Elevate your healthcare innovation to the next level
#465 Early warning system for intensive care units
#466 Eleven finalists have been chosen for the first ever Lyfebulb-Helsinn Innovation Summit & Award in Oncology
#467 Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune cell engager platform
#468 x-cardiac – Artificial Intelligence detects complications before they occur
#469 Bayer’s Expert Mondays - Elevate your healthcare innovation to the next level
#470 Key Topics
#471 Press release: Translational Bioethics Expert Daniel Strech joins the QUEST Center
#472 Targeting chronic inflammation: Prof. Dr. Eicke Latz starts at Charité and German Rheumatism Research Centre
#473 Charité and BIH develop digital data processing infrastructure
#474 GLYCOBIOTECHNOLOGY SYMPOSIUM
#475 Call for Tender “Stress reduction of patients, undergoing surgical interventions, during the entire care path”
#476 RegMed Forum 2023 | ATMPs – Thinking Big, Inclusive and Beyond Rare Disease!
#477 Newsweek rankings 2023 - Charité named one of the world’s best hospitals –
#478 European Biotech & Pharma Virtual Partnering Conference 2021
#479 Novel disease models for multiple myeloma
#480 BIO-Europe 2024 - Europe's largest partnering conference serving the global biotechnology industry
#481 Max Delbrück Center has successfully generated genetically defined mouse models for two subtypes of multiple myeloma
#482 Heart Attack and Stroke Risk Also Elevated in Women with Obesity Who Are Metabolically Healthy
#483 Speed Lecture Award 2019: application phase extended
#484 Eckert & Ziegler Cooperates with Czech Research Center UJF to Produce Pharmaceutical Alpha Radioisotopes
#485 The Hybrid Mind | Ethics and Regulation of Intelligent Neuroprostheses
#486 CO.DON - successful conclusion of Phase II trial “co.dis” demonstrates efficacy and safety of the EU-authorised pharmaceutical product Spherox
#487 German-Polish Dialogue on the Healthcare Sector
#488 RDIF and Minapharm Agree to Produce over 40 Million Doses of the Sputnik V Vaccine in Egypt
#489 Advanced Material Competition 2019 - Call for Start-ups is open!
#490 Building Bridges, Beating Cancer, An #EUnite Event
#491 Comprehensive cancer medicine: Charité partners with oncology center in Seoul
#492 Machine learning improves the diagnosis of patients with head and neck cancers
#493 AM Medical Days
#494 Portrait: Takeda lives diversity
#495 Eckert & Ziegler and PRECIRIX Sign Agreement on Priority Supply of the Therapeutic Radioisotope Actinium-225 (Ac-225)
Show more items
